APERC Orders Rs 9.2 Billion Refund To Power Consumers
ECONOMY & POLICY

APERC Orders Rs 9.2 Billion Refund To Power Consumers

The Andhra Pradesh Electricity Regulatory Commission (APERC) has ordered state power distribution companies to refund Rs 9.2 billion to consumers under its Fuel and Power Purchase Cost Adjustment (FPPCA) True-Up order for FY25.
The refunds will be paid in 12 equal monthly instalments starting November 2025 at Rs 0.13 per unit of electricity. According to APERC, DISCOMs had collected Rs 27.9 billion during 2024-25 at 40 paise per unit monthly. After accounting for this collection, the net refundable amount was calculated at Rs 9.23 billion for FY25.
Political reactions followed the order. The Telugu Desam Party (TDP) claimed the state’s power sector had achieved a “turnaround” under Chief Minister N Chandrababu Naidu, citing savings of Rs 8.95 billion.
Meanwhile, Andhra Pradesh Congress Committee (APCC) chief YS Sharmila criticised the government, alleging that claims of consumer relief were misleading. She stated that during 15 months of NDA coalition rule, a true-up burden of Rs 157.8 billion was imposed on consumers.

The Andhra Pradesh Electricity Regulatory Commission (APERC) has ordered state power distribution companies to refund Rs 9.2 billion to consumers under its Fuel and Power Purchase Cost Adjustment (FPPCA) True-Up order for FY25.The refunds will be paid in 12 equal monthly instalments starting November 2025 at Rs 0.13 per unit of electricity. According to APERC, DISCOMs had collected Rs 27.9 billion during 2024-25 at 40 paise per unit monthly. After accounting for this collection, the net refundable amount was calculated at Rs 9.23 billion for FY25.Political reactions followed the order. The Telugu Desam Party (TDP) claimed the state’s power sector had achieved a “turnaround” under Chief Minister N Chandrababu Naidu, citing savings of Rs 8.95 billion.Meanwhile, Andhra Pradesh Congress Committee (APCC) chief YS Sharmila criticised the government, alleging that claims of consumer relief were misleading. She stated that during 15 months of NDA coalition rule, a true-up burden of Rs 157.8 billion was imposed on consumers.

Next Story
Infrastructure Transport

Centre Clears Rs 69.6 Billion Kaziranga Highway Expansion

The Cabinet Committee on Economic Affairs (CCEA), chaired by Prime Minister Narendra Modi, has approved the widening and upgradation of the Kaliabor–Numaligarh section of NH-715 in Assam, including wildlife-friendly measures on the stretch passing through Kaziranga National Park. The 85.7 km project will be executed in EPC mode at an estimated cost of Rs 69.6 billion.The existing two-lane highway, which runs through Jakhalabandha (Nagaon) and Bokakhat (Golaghat), passes along the boundary of Kaziranga. Seasonal flooding often forces animals to cross the busy road towards the Karbi Anglong Hi..

Next Story
Infrastructure Urban

Govt Approves 57 New Kendriya Vidyalayas Worth Rs 58.6 Billion

The Cabinet Committee on Economic Affairs (CCEA), chaired by Prime Minister Narendra Modi, has approved the establishment of 57 new Kendriya Vidyalayas (KVs) across India under the civil sector to meet the educational needs of children of Central Government employees. The total estimated outlay is Rs 58.6 billion over nine years from 2026–27, including Rs 25.9 billion for capital expenditure and Rs 32.8 billion for operational costs.For the first time, these schools will include Balvatikas (three years of foundational pre-primary stage) as part of the National Education Policy (NEP) 2020 fra..

Next Story
Infrastructure Urban

Govt Invites Proposals Under Rs 50 Billion Pharma-MedTech Scheme

The Department of Pharmaceuticals has opened applications for research and innovation projects under its Promotion of Research and Innovation in Pharma-MedTech Sector (PRIP) scheme, a landmark initiative aimed at transforming India into a globally competitive, innovation-led hub. With an approved outlay of Rs 50 billion, the scheme is expected to support around 300 projects, catalysing total R&D investment of about Rs 110 billion in new medicines, complex generics, biosimilars and novel medical devices.Revised guidelines have been issued to enhance the scheme’s effectiveness. For early-s..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

Advertisement

Advertisement

Talk to us?